Coronavirus: how countries aim to get the vaccine first by cutting opaque supply deals

The rush to be first. Ivan Krivenko Duncan Matthews, Queen Mary University of London The University of Oxford recently published promising news about the results from the phase one/two trials of the vaccine it is developing for COVID-19. The clinical trials, involving 1,077 volunteers in the UK aged 18-55, showed that the AZD1222 vaccine appeared to be safe and generated …

Shutterstock Katie Louise Flanagan, University of Tasmania and Magdalena Plebanski, RMIT University Prime Minister Scott Morrison announced on Wednesday the Australian government has signed a letter of intent to procure the University of Oxford’s vaccine for SARS-CoV-2 (the virus that causes COVID-19) and to provide it free to all Australians. All the signs are promising so far, as the vaccine …